José Victoria Campos, Ursulo Juárez Herrera, Martín Rosas Peralta, Eulo Lupi Herrera, Héctor González Pacheco, Carlos Martínez Sánchez, Eduardo Chuquiure Valenzuela, Gerardo Vieyra Herrera, Carlos Cardozo Zepeda, Carlos Barrera Sánchez, Jesús Reyes Corona, Evelyn Cortina de la Rosa, Aurora de la Peña Díaz, Raúl Izaguirre Avila, Andrés de la Peña Fernández
UNLABELLED: In this prospective, randomized and controlled study, we compare complications in 2 groups of patients: group 1, enoxaparin 0.8 mg/kg, subcutaneous every 12 hours during 5 days, and group 2, intravenous unfractionated heparin during 5 days, by infusion treated to activate partial tromboplastin time 1.5-2 the upper limit of normal. Blood samples were obtained at 4, 12, 24 hours and at day 5 of treatment, to measure anti-Xa levels, and also, evaluated end points at 30 days, between groups...
July 2002: Archivos de Cardiología de México